# Insulin for Hyperglycemia in Stroke Trial

Study · id `cardio:ct-nct04834362` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04834362](<https://clinicaltrials.gov/study/NCT04834362>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04834362

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 452 participants.

## Technical summary

Registry record NCT04834362. Randomized; no masking; primary purpose treatment. Start 2021-04-05 (actual); primary completion 2021-06-20 (actual). Results posted on 2021-12-06.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 452 participants (enrolled count; ClinicalTrials.gov record NCT04834362, source copy `cardio:ctgov-nct04834362-2021-12-06`, retrieved 2026-10-26)
- Started: 2021-04-05 (actual) (ClinicalTrials.gov record NCT04834362, source copy `cardio:ctgov-nct04834362-2021-12-06`, retrieved 2026-10-26)
- Primary completion: 2021-06-20 (actual) (ClinicalTrials.gov record NCT04834362, source copy `cardio:ctgov-nct04834362-2021-12-06`, retrieved 2026-10-26)
- Completion: 2021-06-25 (actual) (ClinicalTrials.gov record NCT04834362, source copy `cardio:ctgov-nct04834362-2021-12-06`, retrieved 2026-10-26)
- Results first posted: 2021-12-06 (ClinicalTrials.gov record NCT04834362, source copy `cardio:ctgov-nct04834362-2021-12-06`, retrieved 2026-10-26)
- Countries: Bangladesh (ClinicalTrials.gov record NCT04834362, source copy `cardio:ctgov-nct04834362-2021-12-06`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04834362-2021-12-06`, retrieved 2026-10-26)

## The registry's words

- Brief title: Insulin for Hyperglycemia in Stroke Trial
- Condition: Hyperglycemia
- Condition: Stroke, Acute
- Intervention (Drug): Analog Insulin
- Intervention (Drug): Human insulin
- Lead sponsor: National Institute of Neurosciences and Hospital, Dhaka
- Lead sponsor class: OTHER\_GOV

## Connected pages

- Registry condition terms include this condition: Stroke (`core:stroke`)

## Provenance

Content hash: 07cceff8e7432065a8205100c468fd5ac2b118e5478d1a3b36ffe51759ae2e28
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
